News | The Pap Corps

The Pap Corps News

'}}

The Case of the Missing T-Cells

We talk a lot about the hardware that’s going to get us to Mars, but the most important things about human spaceflight is, well, humans! There’s a lot of research going into the impact space travel has on the body. Just think back to Scott Kelly’s year in space.

'}}

Ado-trastuzumab emtansine effective for previously treated HER-2–positive metastatic breast cancer

Ado-trastuzumab emtansine may provide meaningful benefit to patients with HER-2–positive metastatic breast cancer who underwent prior treatment with trastuzumab and pertuzumab, according to retrospective study results.

'}}

Curing childhood cancer will take a multi-pronged attack across many fronts

Over the past years, significant progress has been made in the fight against childhood cancer. Still, more than 15,000 young Americans under the age of 21 will be diagnosed with cancer this year, and more than 1,800 of them will not survive.

'}}

Nano beads fight liver cancer

A new type of Nano bead, a medical magnetic bead, may offer better treatment for some liver cancers. It’s called the LUMI bead and it lets doctors see in real time if the bead is delivered to the target.

'}}

Cancer Link dedicated to finding ultimate cure for breast cancer

If you want to become involved in an effort that is truly saving lives, then join forces with Cancer Link, either as an individual committee member or as a community partner.

'}}

Two Genes May Help Predict Breast Cancer Survival

The activity of two genes may help predict certain breast cancer patients’ chances of survival and guide their treatment, British researchers report. “We have seen major strides in the treatment of breast cancer, but once it begins to spread round the body it is still often fatal,” said Paul Workman. He is chief executive of the Institute of Cancer Research (ICR) in London, which conducted the research.

'}}

Eye Color Determines Risk for Cancer

Clinical and epidemiological data have always pointed to eye cancer being more common among those individuals with light eye coloration and fair skin—however, the genetic mechanisms underlying disease development have been largely unknown. Now new research from investigators at The Ohio State University (OSU) and New York University (NYU) sheds light on specific inherited genetic differences for an increased risk of uveal melanoma, a rare cancer that arises from the pigment cells that determine eye color.

'}}

Sylvester Researchers Expand Firefighters Cancer Initiative with Renewed Funding

Surrounded by firefighters, advocates and lawmakers, researchers at Sylvester Comprehensive Cancer Center announced that they are extending the Firefighters Cancer Initiative started nearly one year ago. The goal of the partnership between South Florida’s only academic-based cancer center and more than a dozen South Florida fire rescue departments is to better understand why firefighters may face a higher risk of cancer and find ways to improve their health and safety.

'}}

UHealth Part of Select Collaborative Using IBM’s Watson to Tackle Major Diseases

UHealth – the University of Miami Health System is part of a cognitive imaging collaborative that will be using IBM’s Watson to bring cognitive imaging into daily practice to help physicians address some of the most challenging illnesses affecting the U.S. population. TheIBM Watson Medical Imaging Collaborative will be used to examine breast, lung, and other cancers; diabetes; eye health; brain disease; and heart disease and related conditions, such as stroke.

'}}

Sylvester Comprehensive Cancer Center Hosts Cancer Moonshot Summit

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine hosted a Cancer Moonshot Summit on June 29 as part of U.S. Vice President Joe Biden’s nationwide effort to make more therapies available to more patients, while also improving our ability to prevent cancer and detect it at an early stage. Across the country, hundreds of cancer centers, hospitals, and patient advocacy groups hosted summits – from Miami to Anchorage, Alaska.

'}}

Molecular Diagnostics Separate Malignant from Benign Melanocytic Tumors

Jeong Hee Cho-Vega, M.D., Ph.D., a skin cancer expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues have shown that a relatively simple, multi-step molecular diagnostic algorithm can help determine whether rare, atypical spitzoid tumors are benign spitz nevi or malignant melanomas. This new protocol could ensure that patients receive the right therapies to match the severity of their tumors. The study was published in the journal Modern Pathology.

'}}

Sylvester Breast Cancer Researchers Receive New Grant from Prevent Cancer Foundation

Dorraya El-Ashry, Ph.D., breast cancer researcher at Sylvester Comprehensive Cancer Center and associate professor of medicine at the University of Miami Miller School of Medicine, as well as co-principal investigator Marc E. Lippman, M.D., Deputy Director of Sylvester and Kathleen & Stanley Glaser Professor at the Miller School, recently received a $126,000 grant from the Prevent Cancer Foundation to study the early detection of breast cancer metastasis. The grant will be paid out over one year.